Medicine and Dentistry
Myocardial Infarction
100%
Coronary Angiography
66%
Revascularization
66%
Aortic Stenosis
59%
Coronary Artery Disease
58%
Troponin
56%
Heart Muscle Injury
53%
Computer Assisted Tomography
52%
Cardiac Troponin
48%
Troponin T
48%
Percutaneous Aortic Valve Replacement
48%
Major Adverse Cardiac Event
47%
Acute Coronary Syndrome
40%
Emergency Department
37%
Diagnosis
36%
Cardiovascular System
36%
Atrial Fibrillation
30%
Stenosis
29%
Randomized Clinical Trial
29%
Diagnostic Accuracy
29%
Maturity Onset Diabetes of the Young
27%
Fibrillation
27%
Antithrombotic
27%
Heart Muscle Revascularization
26%
Hazard Ratio
22%
Placebo
22%
Diabetes
21%
Coronary Computed Tomography Angiography
21%
Percutaneous Coronary Intervention
21%
Computed Tomography Angiography
18%
Combination Therapy
18%
Angiography
17%
Aortic Valve
17%
Stable Angina Pectoris
16%
Base
16%
Thorax Pain
16%
Body Mass Index
15%
Aortic Valve Replacement
15%
Myocardial Disease
15%
Cardiovascular Disease
14%
Injury
13%
Cardiovascular Disease Risk Factor
13%
Sex Difference
13%
Cardiovascular Imaging
13%
Multidetector Computed Tomography
13%
Morbid Obesity
13%
Aortic Valvuloplasty
13%
In-Stent Restenosis
13%
Technology Assessment
13%
C Reactive Protein
13%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
68%
Low Density Lipoprotein Cholesterol
55%
Evolocumab
55%
Alirocumab
50%
Placebo
48%
Statin (Protein)
45%
Troponin
38%
Heart Muscle Injury
37%
Lipoprotein A
27%
Non Insulin Dependent Diabetes Mellitus
27%
Acute Coronary Syndrome
27%
Cardiovascular Disease
21%
Proprotein Convertase 9
20%
Troponin T
18%
Coronary Artery Disease
17%
Ezetimibe
16%
Hypercholesterolemia
13%
Chronic Kidney Failure
13%
Antivitamin K
13%
Sitagliptin
13%
Anticoagulant Agent
13%
Randomized Controlled Trial
13%
Frailty
13%
Major Adverse Cardiac Event
13%
Acute Heart Infarction
12%
Cerebrovascular Accident
10%
Atrial Fibrillation
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Adverse Event
7%
Unstable Angina Pectoris
6%
Impaired Glucose Tolerance
6%
Adenosine
6%
Physical Disease by Body Function
6%
Congestive Heart Failure
5%
Cohort Study
5%
All Cause Mortality
5%
Nursing and Health Professions
Heart Infarction
27%
Heart Muscle Injury
27%
Fractional Flow Reserve
27%
Revascularization
18%
Confidence Interval
16%
Treatment Outcome
15%
Base
14%
Percutaneous Coronary Intervention
13%
Antivitamin K
13%
Transcatheter Aortic Valve Implantation
13%
Anticoagulant Agent
13%
International Normalized Ratio
13%
Clinical Audit
13%
Ankle Brachial Index
13%
Intermittent Claudication
13%
Reimbursement
13%
Aortic Stenosis
13%
Health Care
13%
Combination Therapy
13%
Multidetector Computed Tomography
13%
In-Stent Restenosis
13%
Advisory Committee
13%
Biomedical Technology Assessment
13%
Injury
13%
Heart Surgery
13%
Clinical Decision Making
13%
Coronary Angiography
13%
Diagnosis
13%
Standard
13%
Odds Ratio
9%
Major Adverse Cardiac Event
9%
Limit of Quantitation
5%
Acute Heart Infarction
5%
Troponin T
5%
Atrial Fibrillation
5%
